Publicaciones (41) Publicaciones de Daniel Bachiller Pérez

2020

  1. Generation of a human iPSC line (IMEDEAi008-A) derived from natural homozygous CCR5-Δ32 PBMCs enriched in the pro-erythroblast population

    Stem Cell Research, Vol. 47

  2. Generation of one iPSC line (IMEDEAi007-A) by Sendai Virus transduction of PBMCs from a Psoriasis donor

    Stem Cell Research, Vol. 47

  3. New Bicistronic TALENs Greatly Improve Genome Editing

    Current Protocols in Stem Cell Biology, Vol. 52, Núm. 1

  4. iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 858-870

2019

  1. Corrigendum to: “Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients” (Stem Cell Research (2018) 29 (1–5), (S1873506118300746) (10.1016/j.scr.2018.03.004))

    Stem Cell Research

  2. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene

    Stem Cell Research, Vol. 37

  3. Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 18, pp. 101-111

2018

  1. Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients

    Stem Cell Research, Vol. 29, pp. 1-5

  2. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B

    Stem Cell Research, Vol. 32, pp. 110-114

  3. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient

    Stem Cell Research, Vol. 33, pp. 180-184

2016

  1. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients

    Journal of Cystic Fibrosis, Vol. 15, Núm. 5, pp. 611-618

  2. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 498, Núm. 1-2, pp. 263-273

  3. Stability study of sodium colistimethate-loaded lipid nanoparticles

    Journal of Microencapsulation, Vol. 33, Núm. 7, pp. 636-645

2014

  1. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 477, Núm. 1-2, pp. 485-494

2013

  1. Generation of Mouse and Human Induced Pluripotent Stem Cells (iPSC) from Primary Somatic Cells

    Stem Cell Reviews and Reports, Vol. 9, Núm. 4, pp. 435-450

  2. Tracheal oxalosis associated with Aspergillus niger tracheobronchitis

    European Respiratory Journal

2012

  1. IV delivery of fluorescent beads

    Chest

  2. Optimized Protocol for Derivation of Human Embryonic Stem Cell Lines

    Stem Cell Reviews and Reports, Vol. 8, Núm. 3, pp. 1011-1020

2007

  1. Abnormal venous and arterial patterning in chordin mutants

    Developmental Dynamics, Vol. 236, Núm. 9, pp. 2586-2593

  2. Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: A new susceptibility factor for mental retardation

    European Journal of Human Genetics, Vol. 15, Núm. 6, pp. 658-663